ClearPoint Neuro CEO Buys 21,000 Shares Amid Volatility, Betting on a Rebound【News Flash】
ClearPoint Neuro CEO buys 20,942 shares after modest revenue jump—insider confidence amid volatile stock, signaling possible future upside.
4 minutes to read
ClearPoint Neuro Inc
ClearPoint Neuro C‑Suite Swaps Shares in Coordinated Move Ahead of Earnings Surge
ClearPoint Neuro insiders boost confidence: CEO buys 47k shares before March 17 earnings, while top execs sell restricted units – a strategic equity shift worth watching.
4 minutes to read
ClearPoint Neuro Insider Moves: CBO Stigall Buys, Sells, and Loses 35k Shares Amid Market Buzz and Negative Sentiment
ClearPoint Neuro insider activity: CEO Stigall’s recent RSU purchase and tax‑sell moves signal confidence yet spark market scrutiny amid a steep share decline and high buzz—what does it mean for investors?
3 minutes to read
ClearPoint Neuro COO’s Buy‑Sell Trade Signals Confidence Amid Stock Dip and 35% Weekly Slide
Insider activity at ClearPoint Neuro shows the COO buying as the price dips—indicating confidence in a gene‑therapy turnaround and potential rebound.
3 minutes to read
ClearPoint Neuro COO Sees Value in Low Stock: Execs Load Up on RSUs Amid Market Surge
ClearPoint Neuro insider buying signals rising confidence: COO, CEO, and CFO all buying RSUs, hinting at undervalued shares and future upside.
3 minutes to read
ClearPoint Neuro CEO Buys Shares After Selling at Premium, Signals Balanced Insider Confidence【News Flash】
ClearPoint Neuro CEO’s 20‑share buy‑sell pattern under a 10b5‑1 plan shows balanced confidence—sell at premium, buy low, and hold a sizable stake as the company pushes biopharma growth.
3 minutes to read